dornase alfa

Ukraine

Drugs containing this active substance

  • PULMOZYME

    The drug is indicated to improve lung function in patients aged 5 years and older with cystic fibrosis, if the forced vital capacity is greater than 40% of the predicted value.

    Form: solution, for inhalation

    Active substance Dosage
    dornase alfa 2.5 mg/2.5 ml

    ATC: R05CB13

    Manufacturer: Woodstock Sterile Solutions Inc. (primary packaging, manufacturing of unpackaged products)